Stock TRANSCEPT PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Official Publications Transcept Pharmaceuticals Inc Nasdaq

Equities

US89354M1062

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Transcept Pharmaceuticals Inc
05/03 Paratek Pharmaceuticals Announces Positive Efficacy Data for Nuzyra® as Post-Exposure Prophylaxis of Inhalational Anthrax, Triggering Additional Procurement Under Barda Project Bioshield Contract CI
16/01 Paratek Pharmaceuticals, Inc. Promotes Jonathan Light to General Counsel, Corporate Secretary and Chief Compliance Officer CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. PRTK Stock
  4. Stock
  5. News Transcept Pharmaceuticals Inc
  6. Official Publications